7YS-12370-26428
2 vaccinations
4 coded responses
25 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 551 / MN
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-10
Dose 1 — Moderna
-
2021-02-11
Registered in v-safe
-
2021-02-11
Survey response — days 1–6 daily, dose 1MedDRA: Neuralgia, Sensitive skin — Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Nerve pain causing sensitive skinMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-24
- 2021-03-03
-
2021-03-11
Dose 2 — Moderna
- 2021-03-11
-
2021-03-12
Survey response — days 1–6 daily, dose 2MedDRA: Dermatitis allergic, Neuralgia, Tenderness — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Skin sensitivity and tendernessnerve painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-13
Survey response — days 1–6 daily, dose 2MedDRA: Sensitive skin — Feeling: Good · Site: PainFree text: Some skin sensitivityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
-
2021-06-10
Survey response — 3 months, dose 2MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Pregnancy-related symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-11
- 2022-03-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-10 | Moderna | |
| 2 | 2021-03-11 | Moderna |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Nerve pain causing sensitive skin
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Skin sensitivity and tendernessnerve pain
Systemic reaction (other): Some skin sensitivity
Release 9 — 3 months, dose 2
Symptoms: Pregnancy-related symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Dermatitis allergic | ✓ | ✓ | ✓ |
| SRO | Neuralgia | ✓ | ✓ | ✓ |
| SRO | Sensitive skin | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release